Align Technology, Inc. with ticker code (ALGN) now have 12 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $350.00 and $215.00 suggesting an average Analsyt target price of $306.21. Now with the previous closing price of $316.88 this now indicates there is a potential downside of -3.4%. It’s also worth noting that there is a 50 day moving average of $275.27 and the 200 day MA is $292.54. The market cap for the company is 23.81B. The current share price for the company is: $310.84 USD
The potential market cap would be $23,005,328,443 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 53.5, revenue per share of $50.54 and a 6.83% return on assets.
Align Technology, Inc. is a medical device company. The Company is primarily engaged in the design, manufacture and marketing of Invisalign clear aligners for the treatment of malocclusions, or the misalignment of teeth, by orthodontists and general dental practitioners (GPs), Vivera retainers for retention, iTero intraoral scanners and services for dentistry, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software. It operates through two segments: Clear Aligner and Imaging Systems and CAD/CAM Services (Systems and Services). Its Clear Aligner segment consists of Comprehensive Products, which includes Invisalign Comprehensive and Invisalign First; Non-Comprehensive Products, which includes Invisalign Moderate, Lite and Express packages and Invisalign Go, and Non-Case products, which include retention products, Invisalign training, adjusting tools used by dental professionals. Its Systems and Services segment consists of iTero intraoral scanning systems.
